GVS-12 attenuates non-alcoholic steatohepatitis by suppressing inflammatory responses via PPARγ/STAT3 signaling pathways

Non-alcoholic steatohepatitis (NASH), a type of fatty liver disease, is characterized by excessive inflammation and fat accumulation in the liver. Peroxisome proliferator-activated receptor γ (PPARγ) agonist rosiglitazone has great potential in protecting against the development of NASH. However, lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhui, Zhang, Xiyang, Yuan, Bo, Lu, Xi, Zheng, Dongxuan, Zhang, Kefeng, Zhong, Mingli, Xu, Xiaotian, Duan, Xiaoqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2019
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062151/
https://www.ncbi.nlm.nih.gov/pubmed/35520738
http://dx.doi.org/10.1039/c8ra10178g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062151/
https://www.ncbi.nlm.nih.gov/pubmed/35520738
http://dx.doi.org/10.1039/c8ra10178g

Ejemplares similares